1Department of Pathology, Cancer Genome Center and Thyroid Disease Center, Izumi City General Hospital, Izumi, Osaka, Japan
2Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
3Department of Pathology, Shanghai Sixth People’s Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
4Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan
5Department of Pathology, Kameda Medical Center, Kamogawa, Chiba, Japan
6Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
7Special Task Force for Activating Research (STAR), Department of Pathology, Chulalongkorn University, Bangkok, Thailand
8Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
9Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
© 2023 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ethics Statement
Not applicable.
Availability of Data and Material
A publication list by Asian WG member is available as a Supplementary Table S1.
Code Availability
Not applicable.
Author contributions
Conceptualization: KK. CKJ. Data curation: KK, CKJ, HGV, JFH. Formal analysis: KK. Funding acquisition: KK. Investigation: KK. Methodology: all authors. Project administration: KK. Resources: KK. Supervision: KK. Validation: all authors. Visualization: KK, CKJ, HGV, JFH. Writing—original draft: KK. Writing—review & editing: KK, CKJ, HGV, JFH. Approval of final manuscript: all authors.
Conflicts of Interest
C.K.J., the editor-in-chief, along with K.K., Z.L., A.B., and C.-R.L., who are contributing editors of the Journal of Pathology and Translational Medicine, were not involved in the editorial evaluation or decision to publish this article. All other authors have declared no conflicts of interest.
Funding Statement
No funding to declare.
No. | Author(s) | Title | Volume, page |
---|---|---|---|
1 | Kakudo K [77] | Non-invasive encapsulated/well-circumscribed follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and precursor thyroid tumors | 6(1):1-2 |
2 | Kakudo K [78] | Unsettled issues in non-invasive encapsulated/well-circumscribed follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and precursor thyroid tumors | 6(1):3-7 |
3 | LiVolsi VA, Baloch ZW [79] | Coming to terms with diagnosis “Non-invasive follicular neoplasm with papillary-like nuclear features (NIFTP)’: practice changer in endocrine pathology | 6(1):8-13 |
4 | Kakudo K, Liu Z, Satoh S, Higuchi M, Hirokawa M [80] | Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): diagnosis and differential diagnoses | 6(1):14-21 |
5 | Liu Z, Song Y, Han B, Zhang X, Su P, Cui X [81] | Non-invasive follicular thyroid neoplasm with papillary-like nuclear features and the practice in Qilu Hospital of Shandong University, China | 6(1):22-25 |
6 | Jung CK, Kim C [82] | Effect of lowering the diagnostic threshold for encapsulated follicular variant of papillary thyroid carcinoma on the prevalence of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institution experience in Korea | 6(1):26-28 |
7 | Pusztaszeri MP, Triponez F, Meyer P, Sadowski SM [83] | Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): report of an institutional experience with 86 cases | 6(1):29-35 |
8 | Rossi ED [84] | NIFTP diagnosis: roses and thorns for cytopathologists and histopathologists | 6(1):36-37 |
9 | Canberk S, Baloch ZW, Ince U, Schmitt F [85] | Diagnosis of non-invasive follicular tumor with papillary-like nuclear features (NIFTP): a practice changer for thyroid fine-needle aspiration interpretation | 6(1):38-43 |
10 | Maletta F, Volante M, Papotti M [86] | Experience on NIFTP cytology, with a mini meta-analysis of the literature | 6(1):44-50 |
11 | Ng D, Can NT, Ma ZV, van Zante A, Ljung BM, Khanafshar E [87] | Cytomorphologic features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a comparison with infiltrative follicular variant of papillary thyroid carcinoma | 6(1):51-56 |
12 | Saglietti C, Bongiovanni M [88] | The value of cytological examination in the diagnosis of noninvasive thyroid neoplasm with papillary-like nuclear features (NIFTP) | 6(1):57-60 |
13 | Wu HH [89] | The impact of NIFTP on FNA cytology: can we still diagnose papillary thyroid carcinoma? | 6(1):61-62 |
14 | Yang GCH [90] | Ultrasound is cytopathologist’s best friend in the era of noninvasive follicular thyroid neoplasm with papillary-like nuclear features | 6(1):65-67 |
15 | Poller DN, Johnson SJ, Stephenson TJ [91] | Diagnosis of NIFTP in the UK | 6(1):63-64 |
No. | Author(s) | Title | Volume, page |
---|---|---|---|
1 | Bychkov A, Kakudo K, Hong S [49] | Current practices of thyroid fine-needle aspiration in Asia: a missing voice | 51(6):517-520 |
2 | Cha YJ, Pyo JY, Hong SW, et al. [92] | Thyroid fine-needle aspiration cytology practice in Korea | 51(6):521-527 |
3 | Liu Z, Dongge D, Ma B, et al. [93] | History and practice of thyroid fine-needle aspiration in China, based on retrospective study of the practice in Shandong University Qilu Hospital | 51(6):528-532 |
4 | Agarwal S, Jain D [94] | Thyroid cytology in India: contemporary review and meta-analysis | 51(6):533-547 |
5 | Satoh S, Yamashita H, Kakudo K [95] | Thyroid cytology: the Japanese system and experience at Yamashita Thyroid Hospital | 51(6):548-554 |
6 | Abelardo AD [96] | Thyroid fine-needle aspiration practice in the Philippines | 51(6):555-559 |
7 | Hang JF, Hsu CY, Lai CR [97] | Thyroid fine-needle aspiration in Taiwan: the history and current practice | 51(6):560-564 |
8 | Keelawat S, Rangdaeng S, Koonmee S, Jitpasutham T, Bychkov A [98] | Current status of thyroid fine-needle aspiration practice in Thailand | 51(6):565-570 |
9 | Jung CK, Hong S, Bychkov A, Kakudo K [50] | The use of fine-needle aspiration (FNA) cytology in patients with thyroid nodules in Asia: a brief overview of studies from the Working Group of Asian Thyroid FNA Cytology | 51(6):571-578 |
No. | Author(s) | Title | Volume, page |
---|---|---|---|
1 | Kakudo K [14] | Asian and Western practice in thyroid pathology: similarities and differences | 9(5):1614-1627 |
2 | Ohori NP [99] | Molecular testing and thyroid nodule management in North America | 9(5):1628-1638 |
3 | Kumarasinghe MP [100] | Standardisation of thyroid cytology terminology and practice: are modifications necessary? -a narrative review | 9(5):1639-1647 |
4 | Poller DN [101] | Litigation in thyroid cytology and histopathology in England: a very brief overview | 9(5):1648-1652 |
5 | Hirokawa M, Suzuki A, Higuchi M, et al. [102] | The Japanese reporting system for thyroid aspiration cytology 2019 (JRSTAC2019) | 9(5):1653-1662 |
6 | Ito Y, Miyauchi A [103] | Active surveillance of low-risk papillary thyroid microcarcinomas | 9(5):1663-1673 |
7 | Zhu Y, Wu H, Huang B, Shen X, Cai G, Gu X [104] | BRAFV600E mutation combined with American College of Radiology thyroid imaging report and data system significantly changes surgical resection rate and risk of malignancy in thyroid cytopathology practice | 9(5):1674-1684 |
8 | Pusztaszeri MP, Tamilia M, Payne RJ [105] | Active surveillance for low-risk small papillary thyroid cancer in North American countries: past, present and future (bridging the gap between North American and Asian practices) | 9(5):1685-1697 |
9 | Okamoto T, Omi Y, Yoshida Y, Horiuchi K, Abe K [106] | Radioactive iodine treatment of papillary thyroid carcinoma in Japan | 9(5):1698-1707 |
10 | Michael CW, Kameyama K, Kitagawa W, Azar N [107] | Rapid on-site evaluation (ROSE) for fine needle aspiration of thyroid: benefits, challenges and innovative solutions | 9(5):1708-1715 |
11 | Liu Z, Sui S, Su P, et al. [108] | The effect of implementing pre-surgical ultrasound-guided fine-needle aspiration biopsy on thyroid surgery, a 6-year interrupted time series analysis in Qilu Hospital of Shandong University | 9(5):1716-1723 |
12 | Canberk S [109] | Precursor and borderline lesions of the thyroid (indolent lesions of epithelial origin): from theory to practice | 9(5):1724-1734 |
13 | Nguyen TPX, Truong VT, Kakudo K, Vuong HG [64] | The diversities in thyroid cytopathology practices among Asian countries using the Bethesda System for Reporting Thyroid Cytopathology | 9(5):1735-1746 |
14 | Oo ZP, Hlaing AM, Kyi KCS, Fukuoka J, Bychkov A [110] | An overview of thyroid fine-needle aspiration practice in Myanmar | 9(5):1747-1753 |
15 | Tangnuntachai N, Rangdaeng S, Koonmee S, Tangjaturonrasme N, Keelawat S [111] | Pathological practice and management of thyroid nodules: a Thai perspective | 9(5):1754-1763 |
16 | Ooi LY, Nga ME [112] | Atypia of undetermined significance/follicular lesion of undetermined significance: Asian vs. non-Asian practice, and the Singapore experience | 9(5):1764-1787 |
17 | Abelardo AD, Sotalbo KCJ [113] | Clinical management of thyroid aspirates diagnosed as atypia of undetermined significance in the Philippines | 9(5):1788-1796 |
18 | Guleria P, Mani K, Agarwal S [114] | Indian experience of AUS/FLUS diagnosis: is it different from rest of Asia and the West? -A systematic review and meta-analysis | 9(5):1797-1812 |
19 | Odate T, Oishi N, Vuong HG, Mochizuki K, Kondo T [115] | Genetic differences in follicular thyroid carcinoma between Asian and Western countries: a systematic review | 9(5):1813-1826 |
20 | Nakra T, Jain D, Agarwal S [116] | Thyroid lymphoproliferative lesions in Asia | 9(5):1827-1837 |
21 | Li Y, Inomata K, Nishihara E, Kakudo K [117] | IgG4 thyroiditis in the Asian population | 9(5):1838-1846 |
22 | Bai Y, Niu D, Yao Q, Lin D, Kakudo K [118] | Updates in the advances of sporadic medullary thyroid carcinoma: from the molecules to the clinic | 9(5):1847-1856 |
23 | Jung CK, Lee S, Bae JS, Lim DJ [119] | Late-onset distant metastases confer poor prognosis in patients with well-differentiated thyroid cancer | 9(5):1857-1866 |
24 | Choden S, Keelawat S, Jung CK, Bychkov A [120] | An affordable immunohistochemical approach to estimate the prevalence of BRAFV600E in large cohort studies—establishing the baseline rate of BRAF mutation in an institutional series of papillary thyroid carcinoma from Thailand | 9(5):1867-1877 |
25 | Rashid FA, Munkhdelger J, Fukuoka J, Bychkov A [121] | Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma— a contemporary systematic review | 9(5):1878-1900 |
FNA, fine needle aspiration; NIFTP, noninvasive follicular thyroid neoplasm with papillary-like nuclear features; WDT, well differentiated tumor; UMP, uncertain malignant potential; PTC-N, papillary thyroid carcinoma type nuclear features; EFVPTC, encapsulated follicular variant of papillary thyroid carcinoma.
The original idea of this histological type-oriented reporting system of thyroid FNA cytology was first proposed by Kakudo et al in 2019 [122] and updated in 2023 [52].
FNA, fine needle aspiration; RAS, rat sarcoma virus; FA, follicular adenoma; FTC, follicular thyroid carcinoma; PDC, poorly differentiated carcinoma; PTC, papillary thyroid carcinoma; BRAF, v-Raf murine sarcoma viral oncogene homolog B; ATC, anaplastic thyroid carcinoma; ML, malignant lymphoma.